| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/06/2011 | EP2303230A2 Methods and compositions for enhanced delivery of macromolecules |
| 04/06/2011 | EP1838737B1 Binding proteins specific for human matriptase |
| 04/06/2011 | EP1723425B1 Method and device for detecting feline immunodeficiency virus |
| 04/06/2011 | EP1721157B1 Use of antibodies to tweak for the treatment of stroke |
| 04/06/2011 | EP1648501B1 Hybrid toxins comprising shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof |
| 04/06/2011 | EP1529113B1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 04/06/2011 | EP1411979B1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/06/2011 | EP1291424B1 Gasc1 gene |
| 04/06/2011 | CN1981866B DC vaccine for treating chronic hepatitis B |
| 04/06/2011 | CN1930283B Leukocyte stimulation matrix |
| 04/06/2011 | CN1910284B Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 04/06/2011 | CN1774447B S. pneumoniae antigens |
| 04/06/2011 | CN1705679B Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group b streptococcus and uses thereof |
| 04/06/2011 | CN102007147A Anti-cd27 antibody |
| 04/06/2011 | CN102006888A Treatment of thromboangiitis obliterans by removal of autoantibodies |
| 04/06/2011 | CN102006887A Antibodies specific for the protofibril form of beta-amyloid protein |
| 04/06/2011 | CN102006886A Therapeutic use of anti-tweak receptor antibodies |
| 04/06/2011 | CN102006885A Fully human anti-vegf antibodies and methods of using |
| 04/06/2011 | CN102006884A Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus |
| 04/06/2011 | CN102006883A Vaccine for protection against lawsonia intracellulars |
| 04/06/2011 | CN102002105A Gene, expression vector, expression method, expression cell and application of human papilloma virus (HPV) 16 E7E6 fusion protein |
| 04/06/2011 | CN102002104A Anti-VEGF monoclonal antibody and medicinal composition containing same |
| 04/06/2011 | CN102002098A Modified flagellin and preparation method and use thereof |
| 04/06/2011 | CN102002049A Antigen and preparation method and application thereof |
| 04/06/2011 | CN102002048A Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 04/06/2011 | CN102000348A Safety evaluation method for local use of medicament mucosa |
| 04/06/2011 | CN102000333A Immunoglobulin (IgY) antibody oral spray for preventing decayed teeth |
| 04/06/2011 | CN102000332A Composite adjuvant for duck bird flu oral mucosal immunization |
| 04/06/2011 | CN102000331A Application of bursin as swine fever vaccine adjuvant |
| 04/06/2011 | CN102000330A Nucleic acid vaccine adjuvant and construction method thereof |
| 04/06/2011 | CN102000329A Improved flagellin mucosa adjuvant from non-pathopoiesia bacteria source and preparation method thereof |
| 04/06/2011 | CN102000328A Method for manufacturing Marek's disease vaccine by utilizing cell factory |
| 04/06/2011 | CN102000327A Mink viral enteritis inactivated vaccine and preparation method thereof |
| 04/06/2011 | CN102000326A Method for producing rabies vaccine for human |
| 04/06/2011 | CN101537186B Vaccine freeze-drying protective agent without gelatin |
| 04/06/2011 | CN101418303B Method for preparing swine fever recombinant subunit vaccine |
| 04/06/2011 | CN101347617B Refined polyvalent anti-snake poison lyophilized blood serum and using method |
| 04/06/2011 | CN101337990B Humanized neutralizing antibody against rabies virus, method for preparing same and use |
| 04/06/2011 | CN101306200B Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| 04/06/2011 | CN101214375B Improved vaccines |
| 04/06/2011 | CN101185757B Vaccine containing composite adjuvant and preparation method thereof |
| 04/06/2011 | CN101152571B Vaccine wine oil adjuvant containing momordica cochinchinensis soap and method for preparing the same |
| 04/06/2011 | CN101116747B Cytosine arabinoside and gland correlated virus composite preparations and uses thereof |
| 04/06/2011 | CN101069743B Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases |
| 04/06/2011 | CN101052411B VLP-antigen conjugates and their uses as vaccines |
| 04/06/2011 | CN101035810B Modulators of hepatocyte growth factor activator |
| 04/06/2011 | CN101035558B Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 04/06/2011 | CN101020054B Inactivated vaccine for preventing and treating paramyxovirus disease of pigeon and its preparation |
| 04/05/2011 | US7919607 Nucleic acids encoding humanized anti-tag 72 CC49 antbodies |
| 04/05/2011 | US7919606 Biological products |
| 04/05/2011 | US7919594 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders |
| 04/05/2011 | US7919588 Netrin receptors |
| 04/05/2011 | US7919576 Immunogenic CD19 peptides |
| 04/05/2011 | US7919301 Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 04/05/2011 | US7919273 Structural variants of antibodies for improved therapeutic characteristics |
| 04/05/2011 | US7919269 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/05/2011 | US7919258 Rapid tuberculosis detection method |
| 04/05/2011 | US7919257 Method for selecting a single cell expressing a heterogeneous combination of antibodies |
| 04/05/2011 | US7919250 Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions |
| 04/05/2011 | US7919104 Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof |
| 04/05/2011 | US7919103 Compound and method for regulating plasminogen activation and cell migration |
| 04/05/2011 | US7919101 Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors |
| 04/05/2011 | US7919100 Soluble and stabilized trimeric form of gp41 polypeptides |
| 04/05/2011 | US7919098 ErbB-3 based methods and compositions for treating neoplasms |
| 04/05/2011 | US7919097 using a composition comprising a multimeric galectin-1 polypeptide; inflammatory bowel disease, food allergies or asthma; Crohn's disease or ulcerative colitis; multiple sclerosis, diabetes, rheumatoid arthritis, or systemic lupus erythematosis |
| 04/05/2011 | US7919096 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 04/05/2011 | US7919095 comprising variable heavy chain region and variable light chain region; encodes by nucleotide sequence; specifically binding Interleukin-6; biodrug treating diseases and disorders associated autoimmune disease rheumatoid arthritis, cancer of carcinoma, breast cancer, prostate cancer, lymphoma |
| 04/05/2011 | US7919094 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 04/05/2011 | US7919092 Notch receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
| 04/05/2011 | US7919090 Antibody therapy |
| 04/05/2011 | US7919089 Pharmaceutical composition comprising a bispecific antibody for EpCAM |
| 04/05/2011 | US7919088 Treatment and delay of onset of synucleinopathic and amyloidogenic disease |
| 04/05/2011 | US7919087 Immunoglobulin fusion fo use indiagnosis, treatment and prevention of cell proliferative, autoimmune, blood and nervous system disorders |
| 04/05/2011 | US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL) |
| 04/05/2011 | US7919084 Methods of diagnosis, prognosis and treatment of cardiovascular disease |
| 04/05/2011 | US7919083 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/05/2011 | US7919081 Hydrogenase deficient bacterial strains |
| 04/05/2011 | US7919076 PH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 04/05/2011 | CA2543928C Optimized expression of hpv 58 l1 in yeast |
| 04/05/2011 | CA2437788C Inflammation-inhibiting compounds |
| 04/05/2011 | CA2436402C Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
| 04/05/2011 | CA2309355C Tissue cement proteins from rhipicephalus appendiculatus |
| 04/05/2011 | CA2300854C Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 04/05/2011 | CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 04/05/2011 | CA2229163C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 03/31/2011 | WO2011038397A2 Peptide adjuvants, vaccines, and methods of use |
| 03/31/2011 | WO2011038302A2 Novel modulators |
| 03/31/2011 | WO2011038139A1 Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane |
| 03/31/2011 | WO2011038110A2 Methods of treating metabolic disease |
| 03/31/2011 | WO2011038069A1 Methods, compositions, and kits for reducing anti-antibody responses |
| 03/31/2011 | WO2011037271A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 03/31/2011 | WO2011037227A1 Agent for prevention of atherosclerosis |
| 03/31/2011 | WO2011037160A1 Antibody capable of recognizing hla class i |
| 03/31/2011 | WO2011037158A1 Modified antibody constant regions |
| 03/31/2011 | WO2011036564A2 Hyperblebbing shigella strains |
| 03/31/2011 | WO2011036562A1 Purification of bacterial vesicles |
| 03/31/2011 | WO2011036539A1 Therapy for enteric infections |
| 03/31/2011 | WO2011035465A1 Specific binding proteins and uses thereof |
| 03/31/2011 | WO2011035422A1 Method of preparing plant-derived vlps |